Pharming Group N.V. (PHAR:NASDAQ) closed at $9.36 on October 16, 2026, down 2.40% on the day. The stock trades 56.1% below its 52-week high of $21.34 and 0.5% above its 52-week low of $9.31. Over the past year, it lost 33.1%. Pharming Group N.V. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -2.60% | -13.17% | -28.60% | -46.73% | -33.14% |
In 252 trading sessions since October 16, 2025, PHAR closed higher on 120 days (48%). Its best day was November 10, 2025 (+13.74%) and its worst was May 7, 2026 (-26.83%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 2 times.
Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on the development and production of human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. Most of the revenue is generated from the United States.
Find more stocks like PHAR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.